Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.5400
+0.0200 (3.85%)
Apr 10, 2026, 3:55 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 40.82 million as of April 10, 2026. Its market cap has decreased by -42.63% in one year.
Market Cap
40.82M
Enterprise Value
41.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 40.82M, a decrease of -54.18%. That is a compound annual growth rate of -14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 40.82M | -1.18% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | 89.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 64.66M |
| NurExone Biologic | 61.67M |
| Sernova Biotherapeutics | 57.84M |
| Medicenna Therapeutics | 50.89M |
| BriaCell Therapeutics | 44.30M |
| MedMira | 38.60M |
| Devonian Health Group | 33.37M |
| Telescope Innovations | 33.13M |